Baum Charles M
- SEC CIK
- 0001579824
No open-market purchases or sales filed in the past year.
Current role at each company
- ACRV Acrivon Therapeutics, Inc.Directoras of Jun 22, 2026
- PMVP PMV Pharmaceuticals, Inc.Directoras of Jun 5, 2026
- PSTX Poseida Therapeutics, Inc.Directoras of Jan 8, 2025
- MRTX Mirati Therapeutics, Inc.Founder, President, and CEOas of Jan 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Baum Charles M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MRTX Mirati Therapeutics, Inc.
Founder, President, and CEO6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 (view filing) | Jan 4 | 1 day | Baum Charles MPresident,Founder,Head of R&D | SSale | −3.65K | $46.60 | −$170.0K | −2.1%168.8K after | |
| Dec 21, 2022 (view filing) | Dec 21 | Same day | Baum Charles MPresident,Founder,Head of R&D | SSale | −9.09K | $40.42 | −$367.5K | −5.0%172.4K after | |
| Nov 28, 2022 (view filing) | Nov 28 | Same day | Baum Charles MPresident,Founder,Head of R&D | SSale | −69.3K | $100.00 | −$6.93M | −35.1%127.9K after | |
| Jan 18, 2022 (view filing) | Jan 18 | Same day | Baum Charles MPresident,Founder,Head of R&D | SSale | −2.52K | $120.48 | −$303.2K | −1.9%127.9K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Baum Charles MPresident,Founder,Head of R&D | SSale | −4.11K | $147.75 | −$607.9K | −3.9%101.2K after | 2 lots |
| Dec 3, 2021 (view filing) | Dec 3 | Same day | Baum Charles MPresident & Head of R&D | SSale | −47.2K | $133.20 | −$6.29M | −29.5%112.7K after | 7 lots |